RxDoctor Payments Data

Wei Ling Guo

Physician Assistant · Sacramento, CANPI 1205991353

Payments from drug & device makers

$1,992in general payments, 2019–2025

Across 101 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$219
  • Lilly USA, LLC$203
  • Novo Nordisk$199
  • Vanda Pharmaceuticals Inc.$189
  • Pfizer$168
  • Biohaven Pharmaceutical Holding Company Ltd.$155
  • plus $860 from 21 others

What the payments were for

  • Food & beverage$1,992100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,992 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$54,353
JardianceEmpagliflozin53$53,723
JanuviaSitagliptin Phosphate57$45,392
OzempicSemaglutide42$39,283
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$36,951
FarxigaDapagliflozin Propanediol18$23,401
TradjentaLinagliptin19$19,226
LinzessLinaclotide27$18,219
Breo ElliptaFluticasone/Vilanterol30$14,786
VascepaIcosapent Ethyl19$8,036
Arnuity ElliptaFluticasone Furoate36$7,232
MyrbetriqMirabegron14$7,084
Spiriva RespimatTiotropium Bromide11$5,751
Albuterol Sulfate HfaAlbuterol Sulfate217$4,822
Icosapent Ethyl14$2,143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$39$78,70083 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$219$58,96990 claims
PfizerEliquis$168$54,35353 claims
MerckJanuvia$86$45,39257 claims
Novo NordiskOzempic$199$39,28342 claims
AbbVieLinzess$80$18,21927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →